In December 2025, Doximity, Inc. reached a US$31,000,000 insurance-funded settlement agreement to resolve a federal securities lawsuit, pending court approval and without any admission of liability or ...

It highlights company’s scale and profitability, double-digit revenue growth and margins above 50%. According to RBC, Doximity’s core advantage is its professional network, which includes about 80% of ...

Doximity Inc’s stock has reached a new 52-week low, closing at $39.92, just pennies above its absolute low of $39.95. This milestone comes as the company experiences a challenging year, marked by a ...

Futures are trading dramatically lower as we start the holiday-shortened trading week, following yesterday’s MLK remembrance day. The futures downdraft this morning is being attributed to President ...

What Happened? A number of stocks jumped in the afternoon session after investors wagered geopolitical tension would be contained following the U.S. military's operation in Venezuela, with the Dow ...

WIPR ’s newly released USA Trade Secrets Rankings highlight the law firms and practitioners operating at the highest level in ...

Tire Rack, America's leading online tire and wheel retailer, has announced the addition of CTEK's premium battery charging and maintenance products to its extensive lineup. This partnership brings U.S ...

Live Oak Bancshares Inc (LOB) is expected to report $0.87 for 4Q. NVE Corp (NVEC) is expected to report for 3Q. Office ...

Unfortunately, my experience is all too common. If you find yourself in a situation like I did, here's what you should do.

Wells Fargo analyst Stan Berenshteyn upgraded Doximity, Inc. (DOCS) from Neutral to Overweight, citing significant upside potential as the stock trades at $41.10 with a target price of $55. This ...

Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced it will report financial results for its fiscal third quarter ended December 31, 2025 after ...

Doximity Inc. (NYSE:DOCS) is one of the oversold stocks to buy now. On December 15, Morgan Stanley upgraded Doximity to Overweight from Equal Weight with a price target of $65, which was increased ...